![Göran Smedegård](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Göran Smedegård
Directeur/Membre du Conseil chez Axcentua Pharmaceuticals AB
Postes actifs de Göran Smedegård
Sociétés | Poste | Début | Fin |
---|---|---|---|
Axcentua Pharmaceuticals AB
![]() Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 17/09/2009 | - |
Historique de carrière de Göran Smedegård
Anciens postes connus de Göran Smedegård
Sociétés | Poste | Début | Fin |
---|---|---|---|
Pharmacia AB | Corporate Officer/Principal | - | 15/01/2009 |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
Innoventus Project AB
![]() Innoventus Project AB Miscellaneous Commercial ServicesCommercial Services Innoventus Project AB engages in the development and commercialization of ideas, projects, and patents in life science. The company was founded on October 6, 2001 and is headquartered in Uppsala, Sweden. | Directeur en chef des Investissements | 17/09/2009 | - |
Fondateur | 17/09/2009 | - | |
OREXO AB | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Suède | 6 |
Opérationnelle
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Chief Investment Officer | 1 |
Sectorielle
Health Technology | 4 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
OREXO AB | Health Technology |
Entreprise privées | 4 |
---|---|
Axcentua Pharmaceuticals AB
![]() Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
Innoventus Project AB
![]() Innoventus Project AB Miscellaneous Commercial ServicesCommercial Services Innoventus Project AB engages in the development and commercialization of ideas, projects, and patents in life science. The company was founded on October 6, 2001 and is headquartered in Uppsala, Sweden. | Commercial Services |
Pharmacia AB | Health Technology |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Bourse
- Insiders
- Göran Smedegård
- Expérience